New App Alert: riSCC Assesses the Risk of cSCC Recurrence
Meet riSCC, a new data-driven app designed for risk stratification of cutaneous squamous cell carcinoma (cSCC) in clinical settings. Launched by the not-for-profit organization Skin Cancer Consortium Outcomes (SCOUT), riSCC is built from a multinational study of over 20,000 tumors. It will be used by clinicians to analyze patient and tumor characteristics to generate an evidence-based […]